AQR Capital Management’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.53M Buy
1,802,345
+643,799
+56% +$1.51M ﹤0.01% 1974
2025
Q4
$3.14M Buy
1,158,546
+756,209
+188% +$2.48M ﹤0.01% 1850
2025
Q3
$1.7M Buy
402,337
+223,236
+125% +$981K ﹤0.01% 2082
2025
Q2
$892K Sell
179,101
-103,219
-37% -$448K ﹤0.01% 2279
2025
Q1
$1.25M Buy
282,320
+156,482
+124% +$734K ﹤0.01% 1886
2024
Q4
$585K Buy
+125,838
New +$692K ﹤0.01% 2163
2024
Q3
Sell
-46,159
Closed -$360K 2808
2024
Q2
$360K Buy
46,159
+29,741
+181% +$220K ﹤0.01% 2199
2024
Q1
$117K Sell
16,418
-38,593
-70% -$255K ﹤0.01% 2324
2023
Q4
$369K Buy
+55,011
New +$310K ﹤0.01% 1999
2023
Q3
Sell
-87,232
Closed -$482K 2336
2023
Q2
$482K Buy
87,232
+3,834
+5% +$20.6K ﹤0.01% 1798
2023
Q1
$521K Sell
83,398
-186,259
-69% -$1.04M ﹤0.01% 1768
2022
Q4
$1.26M Buy
269,657
+94,041
+54% +$463K ﹤0.01% 1472
2022
Q3
$820K Buy
+175,616
New +$1.11M ﹤0.01% 1592

Other funds holding GDRX

AQR Capital Management's GDRX Position: Q1 2026 in Review

AQR Capital Management increased its GoodRx Holdings (GDRX) stake by 56% in Q1 2026, buying an estimated $1.51M and bringing the position to 1,802,345 shares worth $3.53M. The position accounts for ﹤0.01% of the portfolio, ranked #1974.

AQR Capital Management first reported a position in GDRX in Q3 2022 and has held it in 13 quarters since. 174 funds tracked by Wall St. Rank hold GDRX as of Q1 2026.

  • AQR Capital Management held 1,802,345 shares of GoodRx Holdings worth $3.53M as of Q1 2026.
  • AQR Capital Management bought 643,799 GoodRx Holdings shares in Q1 2026, an estimated $1.51M.
  • GoodRx Holdings made up ﹤0.01% of AQR Capital Management's portfolio in Q1 2026, its #1974 holding.
  • AQR Capital Management first reported a position in GoodRx Holdings in Q3 2022 and has held it in 13 quarters since.
  • 174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2026.

Based on AQR Capital Management's 13F filing for Q1 2026, filed 15 May 2026.